Clopidogrel for High Atherothrombotic Risk, Ischemic Stabilization, Management, and Avoidance - CHARISMA

Description:

The goal of the trial was to evaluate antiplatelet treatment with aspirin alone compared with aspirin plus clopidogrel among high-risk patients with stable cardiovascular (CV) disease.